MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells.

Zhu, Yan; Sun, Jin-Min; Sun, Zi-Chen; Chen, Feng-Jiao; Wu, Yong-Ping; Hou, Xiao-Yu.

Afiliação

Zhu Y; Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.
Sun JM; State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Sun ZC; Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.
Chen FJ; State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Wu YP; Laboratory of Clinical and Experimental Pathology, Department of Pathology, Xuzhou Medical University, Xuzhou, China.
Hou XY; Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.

Front Oncol ; 10: 600762, 2020.

Article em En | MEDLINE | ID: mdl-33692940

Palavras-chave

actin cytoskeleton remodeling; epidermal growth factor receptor kinase substrate 8 (EPS8); glioblastoma prognosis; glioma progression; isocitrate dehydrogenase (IDH); mixed lineage kinase 3 (MLK3); primary and recurrent glioblastoma multiforme (GBM)

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article